A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Clinical trial NCT06499285 · RECRUITING

Trial details

NCT number: NCT06499285
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2025-05-06
Primary completion: 2028-05-01
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.